In Vivo Antiviral Efficacy of a Dipeptide Acyclovir Prodrug, Val-Val-Acyclovir, against HSV-1 Epithelial and Stromal Keratitis in the Rabbit Eye Model
Banmeet S. Anand(Rapt Therapeutics (United States)), Ashim K. Mitra(University of Missouri–Kansas City), Yasser E. Nashed(Amgen (United States)), James M. Hill(University of Oxford), Marvin E. Myles(Louisiana State University Health Sciences Center New Orleans), Surajit Dey(Indian Institute of Technology Kharagpur), Koichi Maruyama(Louisiana State University Health Sciences Center New Orleans), Partha S. Bhattacharjee(National Oceanic and Atmospheric Administration)
Cited by 49
Related Papers
Current and Emerging Developments in Subseasonal to Decadal Prediction
|Bulletin of the American Meteorological Society|2020|311
Current state of the global operational aerosol multi‐model ensemble: An update from the International Cooperative for Aerosol Prediction (ICAP)
|Quarterly Journal of the Royal Meteorological Society|2019|153
Ocular HSV-1 Latency, Reactivation and Recurrent Disease
|Seminars in Ophthalmology|2008|142
Ocular Herpes Simplex Virus: How are Latency, Reactivation, Recurrent Disease and Therapy Interrelated?
|Future Microbiology|2011|116
Drug delivery to the posterior segment of the eye for pharmacologic therapy
|Expert Review of Ophthalmology|2010|99